OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited-stage small cell lung cancer
Yamei Chen, Ying Jin, Xiao Hu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 10, pp. 2867-2876
Open Access | Times Cited: 13
Yamei Chen, Ying Jin, Xiao Hu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 10, pp. 2867-2876
Open Access | Times Cited: 13
Showing 13 citing articles:
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification
Enrico Caliman, Sara Fancelli, Giulia Petroni, et al.
Lung Cancer (2022) Vol. 175, pp. 88-100
Open Access | Times Cited: 22
Enrico Caliman, Sara Fancelli, Giulia Petroni, et al.
Lung Cancer (2022) Vol. 175, pp. 88-100
Open Access | Times Cited: 22
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors
Xiaoling Xu, Ding Wang, Wei Chen, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 12, pp. 4511-4525
Open Access | Times Cited: 15
Xiaoling Xu, Ding Wang, Wei Chen, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 12, pp. 4511-4525
Open Access | Times Cited: 15
Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer
Ashish Saxena
Seminars in Cancer Biology (2023) Vol. 90, pp. 45-56
Closed Access | Times Cited: 6
Ashish Saxena
Seminars in Cancer Biology (2023) Vol. 90, pp. 45-56
Closed Access | Times Cited: 6
Circulating Leukocyte Subsets Before and After a Breast Cancer Diagnosis and Therapy
Jacob K. Kresovich, Katie M. O’Brien, Zongli Xu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2356113-e2356113
Open Access | Times Cited: 1
Jacob K. Kresovich, Katie M. O’Brien, Zongli Xu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2356113-e2356113
Open Access | Times Cited: 1
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
Jie Peng, Dan Zou, Lijie Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 9
Jie Peng, Dan Zou, Lijie Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 9
Chemotherapy to potentiate the radiation-induced immune response
Benoît Lecoester, Mylène Wespiser, Amélie Marguier, et al.
International review of cell and molecular biology (2023), pp. 143-173
Closed Access | Times Cited: 3
Benoît Lecoester, Mylène Wespiser, Amélie Marguier, et al.
International review of cell and molecular biology (2023), pp. 143-173
Closed Access | Times Cited: 3
Changes of proportions of circulating lymphocyte subsets in cancer patients after chemotherapy
Weimin Wang, Yun Wang, Zong Xun Cao
Translational Cancer Research (2021) Vol. 10, Iss. 9, pp. 4169-4179
Open Access | Times Cited: 6
Weimin Wang, Yun Wang, Zong Xun Cao
Translational Cancer Research (2021) Vol. 10, Iss. 9, pp. 4169-4179
Open Access | Times Cited: 6
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal
Deborah E. Citrin, Luca Valle, Kevin Camphausen, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 4
Deborah E. Citrin, Luca Valle, Kevin Camphausen, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 4
The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
Skaistė Tulytė, Dainius Characiejus, Rėda Matuzevičienė, et al.
Anticancer Research (2022) Vol. 42, Iss. 6, pp. 3067-3073
Open Access | Times Cited: 1
Skaistė Tulytė, Dainius Characiejus, Rėda Matuzevičienė, et al.
Anticancer Research (2022) Vol. 42, Iss. 6, pp. 3067-3073
Open Access | Times Cited: 1
T-lymphocyte Subsets Assessment of the Efficacy of PD-L1 Inhibitors in Combination with Chemotherapy in the First-line Treatment of Elderly with Extensive-stage Small Cell Lung Cancer
Zhaoxue Lu, Ying Li, Xuguang Zhang
International Journal of Clinical and Experimental Medicine Research (2023) Vol. 7, Iss. 1, pp. 73-77
Open Access
Zhaoxue Lu, Ying Li, Xuguang Zhang
International Journal of Clinical and Experimental Medicine Research (2023) Vol. 7, Iss. 1, pp. 73-77
Open Access
Clinical Efficacy of Anti-programmed Death Ligand 1 Immunotherapy Combined with Chemoradiotherapy in the Treatment of Limited-stage Small Cell Lung Cancer and Its Effect on Serum Tumor Markers and T Lymphocyte Subsets
Zhaoxue Lu, Shuai Li, Ying Li, et al.
Research Square (Research Square) (2023)
Closed Access
Zhaoxue Lu, Shuai Li, Ying Li, et al.
Research Square (Research Square) (2023)
Closed Access
Dynamic Peripheral Blood Lymphocyte Subsets as Predictive Biomarkers for Langerhans Cell Histiocytosis in Children
Yuhua Feng, Leyuan Wang, Yan Yu, et al.
Research Square (Research Square) (2022)
Open Access
Yuhua Feng, Leyuan Wang, Yan Yu, et al.
Research Square (Research Square) (2022)
Open Access
